Back
Apellis Pharmaceuticals Stock Predictions
Sponsored
APLS
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
APLS
Apellis Pharmaceuticals
Last Price:
36.70
Seasonality Move:
15.53%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmApellis Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.3% based on the past 6 years of stock performance.
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $35.64. The Score for APLS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 23.3% based on the past 6 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
20
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
- Apellis Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
73.80
52-Week Low:
33.49
Prediction Charts
Market Cap:
4.34B
Price in USD:
35.64
Volume:
718.28K
Beta:
0.85
Technical Analysis
SMA50:
38.02
SMA100:
39.74
SMA200:
50.28
52-Wk Change:
-24.17%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company. -
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 35.64 USD today. -
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 38.41 | 38.72 | 39.21 | 38.12 |
Aug-30 | 38.72 | 38.87 | 39.29 | 38.43 |
Sep-3 | 38.36 | 38.79 | 40.35 | 38.18 |
Sep-4 | 38.60 | 37.78 | 39.14 | 37.52 |
Sep-5 | 37.77 | 39.29 | 39.34 | 37.45 |
Sep-6 | 39.67 | 41.05 | 41.64 | 39.38 |
Sep-9 | 41.05 | 39.98 | 41.94 | 39.20 |
Sep-10 | 40.16 | 39.18 | 40.67 | 38.80 |
Sep-11 | 38.97 | 38.36 | 39.51 | 38.10 |
Sep-12 | 38.07 | 36.80 | 38.69 | 36.57 |
Sep-13 | 36.29 | 37.62 | 38.55 | 36.29 |
Sep-16 | 37.50 | 36.31 | 37.55 | 35.52 |
Sep-17 | 36.48 | 35.53 | 36.93 | 35.16 |
Sep-18 | 35.79 | 35.64 | 37.06 | 35.49 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.